ALC:SWX
Alcon AG
CHFÂ 52.84
arrow_upward
+0.30%(+0.16) 1D
Oct 7, 12:01:12 PM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
CHFÂ 52.60
High
CHFÂ 53.06
Low
CHFÂ 52.52
Mkt. cap
26.35B
Avg. vol.
967.80K
Volume
134.37K
Dividend
0.53%
Quarterly dividend
CHFÂ 0.07
Ex-dividend date
May 5, 2026
P/E ratio
48.80
52-wk high
CHFÂ 68.34
52-wk low
CHFÂ 47.80
EPS
CHFÂ 1.08
Shares outstanding
499.70M
No. of employees
25K
Open
CHFÂ 52.60
High
CHFÂ 53.06
Low
CHFÂ 52.52
Mkt. cap
26.35B
Avg. vol.
967.80K
Volume
134.37K
Dividend
0.53%
Quarterly dividend
CHFÂ 0.07
Ex-dividend date
May 5, 2026
P/E ratio
48.80
52-wk high
CHFÂ 68.34
52-wk low
CHFÂ 47.80
EPS
CHFÂ 1.08
Shares outstanding
499.70M
No. of employees
25K
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
Alcon extends Lifecore pact to 2034 as Alcon stock gains 1.25 percent
AD HOC NEWS
·
4 hours ago
Alcon stock pre-market at EUR 56.06: minus 0.05 percent
AD HOC NEWS
·
17 hours ago
Alcon stock after-hours at EUR 56.24: minus 1.88 percent versus the Lang & Schwarz prior close
AD HOC NEWS
·
1 day ago
Alcon stock after-hours at EUR 57.18: plus 1.08 percent versus prior close
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorMedical device
Websitealcon.com